407 related articles for article (PubMed ID: 31726452)
1. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
[TBL] [Abstract][Full Text] [Related]
2. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
3. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
[TBL] [Abstract][Full Text] [Related]
4. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
[TBL] [Abstract][Full Text] [Related]
5. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
Fheodoroff K; Dressler D; Woldag H; Koßmehl P; Koch M; Maisonobe P; Reichel G
Nervenarzt; 2019 Apr; 90(4):361-370. PubMed ID: 30324541
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
Khan P; Riberto M; Frances JA; Chueire R; Amorim ACFG; Xerez D; Chung TM; Mercuri LHC; Longo AL; Lianza S; Maisonobe P; Ruiz-Schutz VC
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33291807
[TBL] [Abstract][Full Text] [Related]
7. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
J Rehabil Med; 2021 Feb; 53(2):jrm00157. PubMed ID: 33616192
[TBL] [Abstract][Full Text] [Related]
10. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
Ghroubi S; Alila S; Elleuch W; Ayed HB; Mhiri C; Elleuch MH
Pan Afr Med J; 2020; 35():55. PubMed ID: 32523646
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
Datta Gupta A; Visvanathan R; Cameron I; Koblar SA; Howell S; Wilson D
BMC Neurol; 2019 May; 19(1):96. PubMed ID: 31078139
[TBL] [Abstract][Full Text] [Related]
13. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
Nott MT; Barden HL; Baguley IJ
J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
[TBL] [Abstract][Full Text] [Related]
14. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
Turner-Stokes L; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Fheodoroff K
BMJ Open; 2016 Jun; 6(6):e011157. PubMed ID: 27315835
[TBL] [Abstract][Full Text] [Related]
15. Therapy influences goal attainment following botulinum neurotoxin injection for focal spasticity in adults with neurological conditions.
Moore EJ; Olver J; Bryant AL; McKenzie DP; Williams G
Brain Inj; 2018; 32(7):948-956. PubMed ID: 29718712
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
Demetrios M; Gorelik A; Louie J; Brand C; Baguley IJ; Khan F
J Rehabil Med; 2014 Sep; 46(8):730-7. PubMed ID: 25073939
[TBL] [Abstract][Full Text] [Related]
17. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
18. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
Ashford S; Turner-Stokes L
Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
[TBL] [Abstract][Full Text] [Related]
20. [The study of the efficacy of Botulinum toxin type A in patients with poststroke upper-limb spasticity ULIS-II: an analysis of Russian patients].
Khat'kova SE; Khasanova DR; Korenko LA; Antipova LN; Shperling LP; Popov DV; Pokhabov DV; Poznyakova EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):89-97. PubMed ID: 26356520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
